Code | 0155E | ||||||||||
MA number | 44/0079/22-S | ||||||||||
Product Form: | tbl flm 30x1x200 mg (blis.Al/PVC/PE/PVDC-jednotliv.dáv.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Zentiva k.s., Czechia | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 31.03.2022 |
Validity: | 31.03.2027 |
Pediatric warnings: | Yes |
SPC: | SPC_Pazopanib Zentiva 200 mg_04.2024.pdf |
PIL: | PIL_Pazopanib Zentiva 200 mg_04.2024.pdf |
Safety feature | Yes |
Data update: | 23.03.2023 |